在美国各地的药房课程中对客观结构化临床检查实践的审查
Kylie N Barnes1, Karen L Hardinger1, Maqual R Graham1
1University of Missouri-Kansas City School of Pharmacy, Kansas City, MO, USA.
American journal of pharmaceutical education
|March 16, 2024
概括
客观结构化临床检查 (OSCE) 在美国药学院越来越多地使用,但实践差异很大. 资源限制是扩大药学学生这些基本评估的常见障碍.
科学领域:
- 药房 教育 教育 药房 教育
- 临床技能评估 临床技能评估
背景情况:
- 目标 结构化临床检查 (OSCE) 对于评估医疗保健专业的临床能力至关重要.
- 美国的药房教育在越来越多地采用欧安组织评估学生表现的方法.
研究的目的:
- 记录美国药学学校目前的欧安组织实践.
- 确定阻碍欧安组织在药房课程中的实施和更广泛使用的挑战.
主要方法:
- 一项调查分发给美国所有认可的药学博士课程.
- 收集的数据包括课程整合,欧安组织设计,交付,评估和实施障碍.
主要成果:
- 81%的受访项目利用了欧安组织,在实施和频率方面存在重大制度差异.
- 大多数计划将欧安组织纳入特定课程,通常是高风险评估;资源限制是扩张的关键障碍.
- 超过一半的项目使用欧安组织的培训学习,突出其在评估和教育中的双重作用.
结论:
- 在过去的十年中,欧安组织在药学教育中采取的措施显著增加.
- 欧安组织在各个项目中如何实施和利用欧安组织的方案存在广泛的差异.
- 尽管在其他卫生领域建立了最佳实践,但欧安组织标准化的最佳实践尚未在药学教育中得到广泛采用.
更多相关视频
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
3.4K
05:04Author Spotlight: Evaluating Clinicians' Adoption of Ultrasound-Guided Vascular Cannulation Through Simulation Training
Published on: August 9, 2024
918
相关概念视频
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Methods of Documentation V: CBE
901
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
901
Drug Administration and Therapy Phases: Overview
460
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
460
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
